These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2798057)

  • 1. [Quantitative assessment of metabolic bone disease in rat models by dual tracer method].
    Ihara F; Seto H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):657-66. PubMed ID: 2798057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous measurements of twenty-four-hour whole-body retention of 47Ca-chloride and 99mTc-MDP: early differentiation of metabolic bone diseases in rat models.
    Seto H; Ihara F; Futatsuya R; Kamei T; Kakishita M; Noda M
    Nucl Med Biol; 1993 Apr; 20(3):337-42. PubMed ID: 8485493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour whole-body retention of 47Ca-chloride: an index of global bone metabolism in rat models.
    Seto H; Ihara F; Kakishita M
    Int J Rad Appl Instrum B; 1989; 16(8):799-804. PubMed ID: 2621115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of 24-hr whole-body retention of 99mTc-MDP with a thyroid uptake probe (author's transl)].
    Seto H; Kakishita M; Futatsuya R
    Radioisotopes; 1981 May; 30(5):263-7. PubMed ID: 6458840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
    Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
    Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biokinetics of osteotropic radiopharmaceuticals in metabolic osteopathy--comparison of 47Ca and 99mTc-methylene-diphosphonate (MDP)].
    Knop J; Montz R
    Nuklearmedizin; 1983 Oct; 22(5):226-31. PubMed ID: 6228781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with two simple methods of measurement of 99mTc-methylene diphosphonate body retention in bone disease.
    Reschini E; Ulivieri FM; Ortolani S
    J Nucl Biol Med (1991); 1991; 35(3):123-30. PubMed ID: 1816867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diets containing different levels of calcium, phosphate, and vitamin D3 on tooth uptake of 47Ca-chloride in rat models: comparison with bone uptake.
    Seto H; Ihara F; Shimizu M; Kageyama M; Futatsuya R; Kakishita M
    Radiat Med; 1992; 10(4):131-4. PubMed ID: 1329154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.
    Mosekilde L; Hasling C; Tågehøj Jensen PC; Tågehøj Jensen F
    Eur J Clin Invest; 1987 Dec; 17(6):530-7. PubMed ID: 3123252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renal failure and metabolic diseases upon bone scanning in children.
    Schümichen C
    Ann Radiol (Paris); 1983; 26(6):498-504. PubMed ID: 6316830
    [No Abstract]   [Full Text] [Related]  

  • 11. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of bone turnover by urinary excretion of 99mTc-MDP.
    Thomsen K; Nilas L; Mogensen T; Christiansen C
    Eur J Nucl Med; 1986; 12(7):342-5. PubMed ID: 3792363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A micro-autoradiographical study of the localization of 99mTc(Sn)-MDP and 99mTc-MDP in undecalcified bone sections.
    Savelkoul TJ; Visser WJ; Oldenburg SJ; Duursma SA
    Eur J Nucl Med; 1986; 11(11):459-62. PubMed ID: 3086099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: quantitative measurement of radioactivity in global skeletal regions of interest.
    D'Addabbo A; Rubini G; Mele M; Lauriero F
    Nucl Med Commun; 1992 Jan; 13(1):55-60. PubMed ID: 1594171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24 hour whole body retention of 99mTc-methylene-diphosphonate in the assessment of bone formation. Methodological evaluation, clinical applications and comparison with serum alkaline phosphatase and serum osteocalcin.
    Hyldstrup L
    Dan Med Bull; 1989 Sep; 36(4):349-58. PubMed ID: 2509145
    [No Abstract]   [Full Text] [Related]  

  • 17. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
    Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
    J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiologic methods of evaluating generalized osteopenia.
    Schneider R
    Orthop Clin North Am; 1984 Oct; 15(4):631-51. PubMed ID: 6387575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
    Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
    Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.